Office of Continuing Education 


501 South Preston Street, Suite 240
Louisville, KY 40202-1701
Telephone: (502) 852-5077
Fax: (502) 852-3994

Wolfe Cancer Symposium
Oral Cancer: An Intensive Course in Early Detection and Prevention

Guest Speaker: Ross Kerr, DDS, MSD

Event Date: Friday, November 14, 2014

Location: Clinical and Translational Research Building - 505 South Hancock Street
Louisville, KY 40202

[Click here for directions]

On-Site Registration/sign-in: 8:00 AM. - 9:00 AM
Course: 9:00 AM - 4:30 PM

Lecture: CEU(s) - 6

Education Method: Live Interactive Format


Course Outline:

8:00 a.m. - 9:00 a.m.

/On-Site Registration

9:00 a.m. – 10:30 a.m.


10:30 a.m. – 10:45 a.m. 


10:45 am. – Noon


Noon – 1:00 p.m.


1:00 p.m. – 2:30 p.m.


2:30 p.m. – 2:45 p.m.


2:45 p.m. – 4:30 p.m.



Course Description:
This intensive evidence-based 6 hour course will cover the epidemiology and biology of oral cancer and potentially malignant oral disorders; elucidate the steps to properly assess, and diagnose patients with suspicious oral lesions, including the use of current and emerging adjunctive diagnostic technologies; and provide insight into the treatment pathways of patients with these diseases, including the management of tobacco dependence. The course will be rich in clinical material and provide opportunity for interactive case discussion.

Course Objectives:

Part 1: Nomenclature, Natural History/Biology & Epidemiology

Clinicians taking this course should be able to:

  1. Understand both the clinical classification (ie before definitive diagnosis) of potentially malignant oral disorders and the histopathological classification (ie definitive diagnosis) of oral and pharyngeal cancers, oral epithelial dysplasia and other oral disorders with malignant potential.
  2. Appreciate the natural history of oral and pharyngeal cancer, including a basic understanding of the biology (ie genetics and epigenetics of oral carcinogenesis), including an overview of the oral microbiome and oral cancer
  3. Know the epidemiology of potentially malignant oral disorders.
  4. Know the epidemiology of oral and pharyngeal cancer including incidence, mortality rates, and survival in terms of age, gender, race/ethnicity, and by staging, both in the United States and globally. In particular, clinicians will be aware of the emerging epidemic of HPV-associated oropharyngeal cancers.
  5. Know the epidemiology and grading of oral epithelial dysplasia, including prevalence and rates of malignant transformation/prognosis both in the United States and globally.
  6. Describe the risk factors and at-risk groups for oral and pharyngeal cancer, oral epithelial dysplasia and other oral disorders with malignant potential.


Part 2: Patient Assessment

Clinicians taking this course should be able to:

  1. Describe the evidence-based recommendations for oral cancer screening.
  2. Know, in detail, the steps taken to evaluate patients for potentially malignant oral disorders. This includes taking a careful history and performing a comprehensive extra-oral and intra-oral soft tissue examination and understanding the basis for the range of symptoms possible in patients with potentially malignant oral disorders.
  3. Understand the evidence for the use of commercially available adjunctive techniques for oral cancer screening.
  4. Understand the importance of record keeping

Part 3: Patient Diagnosis

Clinicians taking this course should be able to:

  1. Describe the visual and tactile features of potentially malignant oral disorders under standard lighting conditions by both extra-oral findings and intra-oral findings ie location, size, color(s), pattern(s)/descriptive terms, and surface topography in relation to surrounding normal tissue. Understand which features are more likely to be associated with malignancy or high-grade epithelial dysplasia and why.
  2. List and characterize and differentiate benign diagnoses with overlapping clinical features.
  3. Appreciate the current clinical evidence supporting or refuting the use of diagnostic adjunctive techniques eg visualization-based adjuncts, vital staining, cytopathological tests, and other emerging diagnostics; their putative mechanisms; their indications and techniques of use; and the spectrum, interpretation and implications of clinical outcomes.
  4. Delineate the clinical steps to arrive at a definitive diagnosis (ie to exclude epithelial dysplasia or squamous cell carcinoma) by developing a differential diagnosis for a potentially malignant oral disorder.
  5. Describe the technique of surgical biopsy and follow-up (ie anesthesia, indications for scalpel vs punch, hemostasis, post-operative instructions, specimen handling, histopathology laboratory requisition, scheduling follow-up for results), and describe the decisions required leading to tissue biopsy (ie medical history contraindications, and determination of selection site or whether to perform an excisional or incisional (single vs multiple) biopsies).
  6. Understand the histopathological diagnosis, including the histopathologic features and staging of oral and pharyngeal squamous cell carcinoma (and other types of oral malignancies ie salivary gland malignancies, sarcomas, lymphomas, melanomas, and others), epithelial dysplasia (mild, moderate, severe, carcinoma in situ), and other disorders with malignant potential.


Part 4: Patient Management and Long-Term Follow-Up

Clinicians taking this course should be able to:

  1. Understand the steps for appropriate referral to experts in the diagnosis and management of patients with oral and pharyngeal malignancies, oral epithelial dysplasia, or other mucosal conditions.
  2. Appreciate the evidence-based treatment options for patients diagnosed with oral and pharyngeal squamous cell carcinoma.
  3. Appreciate the evidence-based management options for patients with oral epithelial dysplasia.
  4. List the steps and the resources for healthcare promotion/education and cessation/modification of avoidable risk factors (including tobacco, areca-nut, heavy alcohol use, nutrition, sexual risk factors and others).
  5. Understand and be able to implement the current evidence-based guidelines for the management of patients with tobacco and alcohol dependence into a dental practice.
  6. Understand the role of the dentist as part of the multi-disciplinary team managing patients with oral cancer and list the oral complications related to the oncologic treatment (both in the short-term and long-term).

Part 5: Case Studies

There will be 4-6 interactive cases that will help summarize the program.

About Ross Kerr, DDS, MSD
Dr. Ross Kerr received his DDS from McGill University in Montreal, Canada, and his MSD and certificate in Oral Medicine at the University of Washington. He is a Diplomate of the American Board of Oral Medicine and Clinical Professor in the Department of Oral & Maxillofacial Pathology, Radiology & Medicine at New York University College of Dentistry where he is the director of the Oral Mucosal Disease Service. He is a steering committee member of the World Workshop on Oral Medicine VI, and the Secretary of the American Academy of Oral Medicine. His research experience includes the management of dry mouth, and the evaluation of current and emerging technologies for the early detection of oral cancer. He has lectured nationally and internationally on dry mouth, oral cancer, and other oral medicine related topics, and has contributed to the dental and medical literature. His private practice is focused on the management of patients with oral mucosal disease, dry mouth, and the dental management of medically complex patients.



FEES On-Line Registration by 11/13/2014 11:59 AM On-Site Registration after 11/13/2014 11:59 AM
Dentist: $225 $260
Hygienist: $180 $215
Auxiliary: $180 $215
Hygienist/Auxiliary w/ Dentist: $170 $205

Register On-Line: (American Express, Discover, Mastercard or VISA only)

****Payment by Check or Money Order available for on-site registration only****


We reserve the right to cancel, modify date, revise course content, revise program faculty and activities. Pre-registered participants will be notified if a course is revised or cancelled, as warranted. In the event a course is cancelled, tuition will be refunded. 

All registrations are subject to the ULSD Cancellation Policy.

ULSD must receive your written request for cancellation not later than two-weeks prior to course start date to process a refund. A $75 processing fee will be deducted from the refund. Course Registrants who are a 'NO-SHOW' forfeit course tuition.

[Click to view Hotels Downtown Louisville]








Powered by